When Jenny Ahlstrom was diagnosed with multiple myeloma in 2010, she was grateful for all the great work being done in myeloma, but saw gaps in support, tools, and funding that she believed could help patients navigate their disease and accelerate a cure.
She created the CrowdCare Foundation and the Myeloma Crowd with three goals: 1) educate and support patients, 2) use data to hasten a myeloma cure, and 3) fund critical research.
The Myeloma Crowd programs include: Myeloma Crowd website (with over 700,000 unique visitors per year), Myeloma Crowd Round Tables, Myeloma Coach (over 100 Coaches), Myeloma Crowd Radio (140 shows to date), Muscles for Myeloma, HealthTree.org (over 5,900 patient participants), and the Myeloma Crowd Research Initiative (funding five investigator projects). The HealthTree platform is first-in-class software that both supports myeloma patients over the lifetime of their disease but also aggregates patient data to rapidly answer critical research questions that could lead us to a cure.
Before becoming the executive director of Life with Cancer and Patient Experience for the Inova Schar Cancer Institute, Jennifer Bires served as the executive director at Smith Center for Healing and the Arts in Washington, D.C., after almost a decade of experience as an oncology social worker in the D.C. area. Bires has a passion for improving access to psychosocial services for those impacted by cancer. She specializes in working with young adults who have been diagnosed with cancer, end-of-life issues for patients and families, and sexual health. Jennifer is the 2017 recipient of the Oncology Social Worker of the Year Award from the Association of Oncology Social Workers.
Craig Cole, MD, is a board-certified hematologist and director of Clinical Research in hematology/oncology and multiple myeloma at the Breslin Cancer Center, Michigan State University College of Human Medicine.
Previously, Dr. Cole was an attending hematologist at Gundersen Health System in La Crosse, Wisconsin for nine years. There he served as an affiliate faculty member of their Graduate Community Health Programs and assistant professor (adjunct) at the University of Wisconsin-La Crosse, Department of Health Professions. He then returned to the University of Michigan Rogel Cancer Center in Ann Arbor, Michigan, as an assistant professor in the Division of Hematology/Oncology with a primary clinical and research interest in multiple myeloma.
Dr. Cole has served as the onsite primary investigator for over 30 clinical trials and participated in more than 50 clinical trials in multiple myeloma and malignant hematology. He is published in national journals and has presented his research at the American Society of Hematology (ASH) and the American Society for Apheresis’s (ASFA) national meetings. Dr. Cole has won awards for his work in teaching, multiple myeloma research, and patient advocacy. His strong commitment to patient empowerment and education is evidenced by his work with several local and national patient advocacy associations.
Dr. Cole received his bachelor of Science degree in physiology at Michigan State University’s College of Lyman Briggs. He went on to receive his MD degree at The Ohio State University College of Medicine. He completed an internal medicine residency and hematology/oncology fellowship at the University of Michigan Health System. Dr. Cole subsequently had a post-fellowship laboratory research position at the Jerome Lipper Multiple Myeloma Center of Medicine at Dana-Farber Cancer Institute in Boston, Massachusetts.
Eric Dallara, RPh, is head pharmacist at the main dispensing pharmacy of New England Cancer Specialists. He has more than 15 years of experience as a pharmacist in the state Maine. In this role, he works closely with New England Cancer Specialists' five full-time financial advocates on both IV and oral medications. He is also involved in the Oncology Care Model (OCM) project.
Kirollos Hanna, PharmD, BCPS, BCOP, is assistant professor of pharmacy at the Mayo Clinic College of Medicine, and primarily practices hematology/oncology pharmacy at the University of Minnesota Medical Center and Mayo Clinic.
Dr. Hanna is a nationally recognized expert in genitourinary cancers, multiple myeloma, and chronic leukemias. His research interests focus on outcome measures for patients with rare diseases. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, American Journal of Health-System Pharmacy, Journal of Oncology Pharmacy Practice, and Journal of Hematology Oncology Pharmacy. He is a member of the 2018 inaugural 40 Under 40 Rising Stars and Emerging Leaders in Cancer class. He is also an active member of the Patient-Centered Outcomes Research Institute, Aplastic Anemia & MDS International Foundation, and the American College of Clinical Pharmacy.
On a national level, Dr. Hanna serves on the executive council for the National Oncology Community Dispensing Association (NCODA) and as president for the Southern Affiliate Chapter of the Minnesota Society of Health-System Pharmacists (MSHP). He is an active member and has been an invited speaker for NCODA, Hematology/Oncology Pharmacy Association, MSHP, among others and has been featured on The Video Journal of Oncology and Specialty Pharmacy Times.
Dr. Hanna received his Doctor of Pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital in Nashville, Tennessee, and his oncology residency at St. Luke's Mountain States Tumor Institute in Boise, Idaho.
Susan Kumka, MSN, RN-BC, APN-C, has over 23 years of experience in the healthcare industry. She is currently employed at Hackensack University Medical Center as an advanced practice nurse for patients with multiple myeloma, Waldenstrom’s macroglobulinemia, and amyloid light-chain (AL) amyloidosis.
Prior to this, she practiced in oncology for two years with a focus in neuro-oncology, hematology, and solid tumors.
To stay involved in the advancements in her field, she participates as a sub-investigator in Phase I and Phase II clinical trials and is active with a myeloma support group.
Susan is board certified by the American Academy of Nurse Practitioners as an Adult Nurse Practitioner. She received her BS degree in nursing and her MS in nursing from William Paterson University with a graduate focus as an Adult Nurse Practitioner.
Jessica Noble, PharmD, RPh, joined The Ohio State University Wexner Medical Center in the Outpatient Pharmacy in January 2017. She accepted the lead retail position in 2018 and took on the challenge of obtaining the first two specialty pharmacy accreditations for Ohio State.
After establishing the patient care management program and numerous other enhancements to patient services, IT, and policies, Ohio State obtained accreditations from URAC and the Accreditation Commission for Health Care (ACHC), and additional distinctions in oncology and HIV from ACHC. Dr. Noble comes to OSU from Walgreens where she served OSU patients as manager of the local specialty pharmacy.
She received her Doctor of Pharmacy from The Ohio State University College of Pharmacy.
She is passionate about making a positive difference for her patients and peers. She enjoys creating opportunities to bring better quality care and education to staff and patients and finds opportunities to facilitate interdisciplinary teams to work together.
Christopher Schumpp, PharmD, is currently the clinical pharmacist, Specialty Pharmacy Services, Ambulatory Pharmacy Services, and a clinical instructor, Pharmacy Practice at the University of Illinois Hospital and Health System System (UI Health), a major academic teaching institution on the near west side of Chicago.
JoAnn Stubbings, BSPharm, MHCA, is Associate Director, Specialty Pharmacy Services at the University of Illinois at Chicago College of Pharmacy. Where she is also a clinical associate professor in the Department of Pharmacy Practice and the Department of Pharmacy Systems, Outcomes, and Policy at the University of Illinois at Chicago College of Pharmacy.
As associate director, Specialty Pharmacy Services, she leads an advanced and well-established health-system based specialty pharmacy team that includes a clinical coordinator, accreditation and residency coordinator, call center and operations coordinator, business coordinator, plus an outstanding group of pharmacists, certified pharmacy technicians, pharmacy residents, and pharmacy students. JoAnn has a comprehensive understanding of how to build a specialty pharmacy, and how to grow the business by overcoming many challenges.
In her role as clinical associate professor at the UIC College of Pharmacy, she understands the role of pharmacy and post-graduation education in specialty pharmacy. JoAnn has developed and implemented modern active learning tools in the classroom and online. Additionally, she spearheaded the creation of an ASHP-accredited Community Pharmacy Residency with a focus on specialty pharmacy.
Kelly Terrell, MBA, BSN, RN, BMTCN, is the nurse manager for the Stem Cell Transplant and Cell Therapy program at Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis, Missouri. She has nine years of experience in oncology, five of which have been in nursing leadership.
Terrell earned her Bachelor of Science degree from Goldfarb School of Nursing at Barnes-Jewish Hospital in St. Louis and her master’s in business administration from Webster University in Missouri.
Jessica Unzaga, PharmD, BCPS, BCOP, is a clinical pharmacy coordinator at the Miami Cancer Institute at Baptist Health South Florida. Dr. Unzaga carries dual board certification in pharmacotherapy (BCPS) and oncology pharmacy (BCOP). She has served many roles in the inpatient and outpatient oncology service lines including inpatient malignant hematology, outpatient oral chemotherapy clinic for solid tumor and hematologic malignancies, and outpatient bone marrow transplantation.
Dr. Unzaga is an active preceptor and mentor for pharmacy students and residents on clinical rotations in hematology and bone marrow transplantation. She is a courtesy clinical assistant professor for the University of Florida College of Pharmacy and invited lecturer for pharmacotherapy of lymphomas and multiple myeloma for the Larkin University College of Pharmacy. Additionally, she is an active member of the Hematology/Oncology Pharmacy Association (HOPA), American Society of Hematology (ASH), American Society of Transplantation and Cellular Therapy (ASTCT), Florida Society of Clinical Oncology (FLASCO), and Florida Society of Health System Pharmacists Southeast Society (SE-FSHP).
She is a graduate of the University of Florida College of Pharmacy and completed her post-graduate year (PGY) 1 and 2 residencies at the Veterans Affairs Tennessee Valley Healthcare System (VA TVHS) in Nashville, Tennessee, at Methodist University Hospital and the West Cancer Center, respectively.